Efficacy and Safety of Tegoprazan-Containing Versus Proton Pump Inhibitor-Containing Regimens for First Line Helicobacter pylori Eradication-An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
BACKGROUND Effective acid-suppressing treatment is of vital importance for the successful eradication of Helicobacter pylori (H. pylori). Tegoprazan, which is a potassium-competitive acid blocker (P-CAB), has been evaluated as a substitute for proton pump inhibitors (PPIs) in first-line eradication therapy, but updated...